Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model

Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer modelRetraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model, Published online: 08 May 2019; doi:10.1038/s41419-019-1606-1Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model

Source: Cell death and disease - May 7, 2019 Category: Internal Medicine Authors: H. Qiao T. Y. Wang Z. F. Yu X. G. Han X. Q. Liu Y. G. Wang Q. M. Fan A. Qin T. T. Tang Source Type: research